Literature DB >> 34111534

Probability of Postoperative Complication After Liver Resection: Stratification of Patient Factor, Operative Complexity, and Use of Enhanced Recovery After Surgery.

Kosuke Kobayashi1, Yoshikuni Kawaguchi2, Michael Schneider3, Giulia Piazza3, Ismail Labgaa3, Joliat Gaëtan-Romain3, Emmanuel Melloul3, Emilie Uldry3, Nicolas Demartines4, Nermin Halkic3.   

Abstract

BACKGROUND: The present study aimed to assess performance of the three-level complexity classification which stratified liver resection procedures into three complexity grades (grade I, low; grade II, intermediate; grade III, high complexity) and to evaluate whether the enhanced recovery after surgery (ERAS) protocol improves postoperative outcomes for each complexity grade. STUDY
DESIGN: Consecutive patients undergoing open liver resection (OLR) and laparoscopic liver resection (LLR) at Lausanne University Hospital during 2010-2020 were assessed.
RESULTS: A total of 437 patients were included. Operative time estimated blood loss, and length of hospital stay increased significantly with a stepwise increase of the grades from I to III in OLR and LLR (all, P<0.05). The same trend for comprehensive complication index (CCI) was found in OLR (P<0.005). Age (P=0.004), the three-level complexity classification (grade II vs. I, P=0.001; grade III vs. I, P<0.001), no use of the ERAS protocol (P=0.016), and biliary reconstruction (P<0.001) were significant predictors for postoperative complication defined as CCI ≥ 26.2 in a multivariable logistic regression analysis. The prediction model incorporating the 4 factors had a calculated concordance index of 0.735 and 0.742 based on the bootstrapping method. The use of ERAS protocol was associated with lower probability of postoperative complication for each complexity grade and age.
CONCLUSION: The use of ERAS protocol may decrease the probability of postoperative complication for each surgical complexity of liver resection and patient age. This finding emphasized the importance for tailoring perioperative managements by surgical complexity and patient age to improve outcomes after liver resection.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  ERAS; complexity; complication; liver resection

Year:  2021        PMID: 34111534     DOI: 10.1016/j.jamcollsurg.2021.05.020

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  5 in total

1.  Liver drains after surgery: what is the real practice? An international snapshot from the Li.DR.A.S. survey.

Authors:  Simone Famularo; Giammauro Berardi; Timothy M Pawlik; Matteo Donadon; Guido Torzilli
Journal:  Updates Surg       Date:  2022-06-03

2.  Commentary: Computational Analysis for ERAS and Other Surgical Processes: Commentary From Clinical Perspective.

Authors:  Hilla Mills; Ronald Acquah; Nova Tang; Luke Cheung; Susanne Klenk; Ronald Glassen; Magali Pirson; Alain Albert; Duong Trinh Hoang; Thang Nguyen Van
Journal:  Front Surg       Date:  2022-06-14

3.  Usefulness of the estimation of physiologic ability and surgical stress (E-PASS) system for prediction of complication and prognosis in hepatocellular carcinoma patients after hepatectomy.

Authors:  Yili Dai; Guoqiao Chen; Yongle Chen; Zhaoqi Shi; Junhai Pan; Xiaoxiao Fan; Hui Lin
Journal:  Transl Cancer Res       Date:  2022-08       Impact factor: 0.496

4.  Risk factors associated with postoperative complications and prolonged postoperative length of stay after laparoscopic liver resection.

Authors:  Haili Zhang; Dufu Kang; Fei Liu; Bo Li; Wei Zhang; Yonggang Wei
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2022-07-13       Impact factor: 1.627

5.  Association between compliance with enhanced recovery after surgery (ERAS) protocols and postoperative outcome in patients with primary liver cancer undergoing hepatic resection.

Authors:  Ka Li; Ruihua Xu; Jinhua Feng; Huan Feng; Qiang Han; Hui Ye; Fuyu Li
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-25       Impact factor: 4.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.